Yosemite Clinic Secures Series A+ Funding Led by Medtronic China Healthcare Fund to Advance Multidisciplinary Outpatient Minimally Invasive Surgery

(Image provided by Yosemite Clinic)

VCBeat (WeChat ID: vcbeat) learned that on April 20, Yosemite Clinic held an investment press conference with Medtronic China Healthcare Fund, announcing that the fund would lead the A+ round of financing for Yosemite Clinic’s parent company. This announcement coincides with the first anniversary of the strategic partnership between Yosemite Clinic and Medtronic Minimally Invasive Therapies. Previously, Yosemite Clinic had secured Series A funding from Legend Capital, Licheng Asset Management, and Zhengqi Financial, and became an official medical consortium partner of Shanghai Tenth People’s Hospital. The current funding round amounts to tens of millions of RMB, with Legend Capital continuing to participate as a follow-on investor. Hooyue Capital served as the exclusive financial advisor for this round.

This financing will provide Medtronic and Yosemite Clinic with opportunities to further deepen their collaboration, leverage their respective strengths, promote the development of multidisciplinary day-case minimally invasive surgery, and facilitate the implementation of tiered diagnosis and treatment under China’s healthcare reform, thereby benefiting more patients in China. The two parties will explore cooperation opportunities in multiple areas, including academic exchange, talent development, clinical practice, and scientific research and innovation.

Day surgery is characterized by its minimally invasive nature, elective scheduling, and rapid recovery. In China, the maximum hospital stay for day surgery does not exceed 48 to 72 hours, and it generally does not involve major or complex procedures. Against the backdrop of China’s healthcare reform accelerating and the tiered diagnosis and treatment system being steadily advanced, factors such as allowing physicians to practice at multiple sites and independently, encouraging social capital to invest in healthcare, decentralizing basic medical services, and the growing public demand for high-quality health services and comprehensive disease management have all created favorable conditions for healthcare providers to develop in the field of day surgery.

Yosemite Clinic is a healthcare institution offering comprehensive medical services. Headquartered in the heart of Pudong, Shanghai, it provides general practice and multi-specialty care, with expertise in minimally invasive surgery. The facility is equipped with advanced diagnostic tools and features Class 100 laminar flow operating rooms that meet stringent cleanliness standards.

Yosemite Clinic primarily focuses on minimally invasive surgical procedures for common, simple, and frequently occurring conditions, providing patients with high-standard day-surgery protocols and high-quality medical services. This serves as an effective complement to the complex and challenging surgeries undertaken by large public hospitals, and represents a concrete action in response to the national initiative to promote tiered diagnosis and treatment, whereby private healthcare institutions assume basic medical needs to better serve patients.

Meanwhile, Yosemite Clinic has partnered with mainstream commercial insurance providers to build a professional, convenient, harmonious, and reassuring medical service platform. Its physicians hail from around the world, offering multilingual services in English, Japanese, Korean, and Chinese. Guided by its vision of “Uniting Global Excellence, Creating a Medical Haven,” Yosemite Clinic is committed to becoming a premier practice platform for outstanding physicians, working together to create a warm and comfortable healthcare haven for patients.

Yosemite Clinic’s Operating Room (Image provided by Yosemite Clinic)

Ambulatory Surgery Centers (ASCs) in the United States have experienced rapid growth. Since the establishment of the first independent ASC in 1970, the number has expanded to over 6,000 facilities, with procedures performed in ASCs now accounting for more than 85% of all surgeries nationwide. Notably, the vast majority of U.S. ASCs were founded by senior physicians with extensive surgical backgrounds. Dr. Song Keying, a surgeon and founder of Yosemite Clinic, pioneered the localization of the U.S. ASC model in Shanghai’s Pudong district through a "micro-hospital" approach. By assembling outstanding medical, nursing, and anesthesia teams from both domestic and international backgrounds, Yosemite Clinic has progressively accumulated clinical experience and operational models tailored to the personalized needs of Chinese patients and healthcare providers. As a global leader in medical technology, services, and solutions, Medtronic continuously delivers cutting-edge therapies and solutions to healthcare systems, medical professionals, patients, and the general public worldwide, boasting an extensive product portfolio and technological reserves in the field of minimally invasive treatment.

In China, Medtronic is a founding organization and the first corporate member of the China Ambulatory Surgery Alliance. The company has successively launched innovative surgical products in the Chinese market, including intelligent endoscopic staplers, absorbable mesh fixation devices, suturing products, and surgical energy platforms, remaining steadfast in its commitment to providing safe, efficient, and reliable minimally invasive treatment solutions for physicians and patients. Meanwhile, Medtronic places significant emphasis on local healthcare innovation in China. In late 2015, it partnered with Sequoia Capital to establish the Medtronic China Healthcare Fund. By leading the Series A+ financing round for the parent company of Yosemite Clinic, the Fund creates further opportunities for collaboration between both parties, aiming to jointly promote the robust development of ambulatory surgery in China and deliver higher-quality healthcare solutions to more Chinese patients.

Leveraging this investment opportunity, both parties will further communicate and explore opportunities for in-depth cooperation. They will engage in more profound academic exchanges in the field of ambulatory surgery, sharing the latest theoretical findings and practical experiences to support the establishment of standardized norms for ambulatory surgery in China. Meanwhile, Medtronic and Yosemite Clinic will jointly conduct clinical skills training, introduce advanced clinical technologies, and, with the support of Medtronic’s Surgical Clinical Training Center, promote interaction and exchange among surgeons, thereby delivering higher-quality care to patients.

As the first ambulatory minimally invasive surgery platform pioneered in China, Yosemite Clinic aims to establish a benchmark model that integrates ambulatory minimally invasive surgical services with advanced technology, thereby maximizing the operational efficiency of independent ambulatory surgery centers. In the future, both parties will jointly explore collaborative models for ambulatory surgery that leverage the complementary strengths of public and private medical institutions. This will foster a cooperative ecosystem characterized by upstream-downstream synergy and the complementarity of advantageous resources, further promoting the adoption of minimally invasive ambulatory surgery across China. The initiative will provide an excellent professional development platform for physicians and deliver warm, high-quality medical services to patients. For instance, by focusing on key specialty areas and collaborating with domestic surgical experts, they will co-create specialized medical services featuring “specialized care for specific conditions.” By combining Yosemite Clinic’s premium ambulatory surgery model with Medtronic’s surgical technologies, this partnership aims to benefit a broader patient population.

Dr. Song Keying, Founder and CEO of Yosemite Clinic, stated, “As we celebrate the first anniversary of the strategic partnership between Yosemite Clinic and Medtronic Innovative Surgery, we are delighted to further deepen our collaboration with Medtronic, leveraging the opportunity of Medtronic China Medical Fund leading the A+ round financing for Yosemite Clinic. Our previous cooperation has already pioneered many beneficial explorations in establishing premium ambulatory surgery centers in China. As a renowned global medical device company, Medtronic holds a leading advantage, particularly in the field of minimally invasive surgical technology. There are numerous opportunities for collaboration between both parties in ambulatory surgery and minimally invasive surgery. In the future, we will continue to uphold ‘clinical medicine + education and training’ as the cornerstone of our development, adhere to the value proposition of ‘patient-centered, physician-led,’ and maintain high standards in clinical practice and operational management. Yosemite Clinic hopes to actively explore and engage in mutual assistance with more partners, aiming to achieve significant breakthroughs and robust growth for ambulatory surgery in China’s premium healthcare market. We are eager to integrate more resources and collaborate with all stakeholders to create a win-win situation.”

Gu Yushao, Senior Vice President of Medtronic globally and President of Greater China, stated, “For nearly 70 years, Medtronic has been continuously exploring the infinite possibilities of medical technology. In response to the growing disease burden and healthcare demands in China, we are committed to fully leveraging the potential of medical technology to deliver innovative, high-quality healthcare solutions to more Chinese patients. We look forward to exploring future collaboration opportunities with Yosemite Clinic to help both parties better leverage their respective strengths in the field of minimally invasive therapy, accelerate the promotion of benchmark premium ambulatory surgery models in China, and benefit a broader patient population.”

Regarding this financing round, Cheng Lifei, Vice President of Medtronic Greater China and Head of the Medtronic China Medical Fund, stated, “The Medtronic China Medical Investment Fund aims to help leading healthcare innovation enterprises deliver high-quality medical solutions to Chinese patients sooner through multi-faceted, multi-role, and diversified collaboration models. We are highly optimistic about Yosemite Clinic’s growth prospects in the field of ambulatory surgery, and we hope this financing will further solidify the company’s pioneering position in the premium ambulatory surgery sector.”

Wang Jianfei, Executive Director at Legend Capital, stated, “Legend Capital adheres to the philosophy of collaborating with like-minded partners to build desired ventures and share in their success. We remain firmly optimistic about the development of ambulatory surgery centers in China and continue to have strong confidence in Dr. Song and his team. We believe that, with the joint support of Legend Capital and an growing number of investors and partners bringing valuable industry resources, Yosemite Clinic will further solidify its position as a leading provider of premium ambulatory surgical services in China.”

Medtronic is a global leader in medical technology, services, and solutions, dedicated to alleviating pain, restoring health, and extending life for millions of people worldwide. On average, more than two patients every second benefit from Medtronic’s medical technologies or therapies. With 84,000 employees across approximately 160 countries, Medtronic serves physicians, hospitals, and patients globally. Working hand in hand with partners to advance healthcare. Further, Together.